Miller Joseph M 4

What Happened
Joseph M. Miller, Chief Financial Officer of Aurinia Pharmaceuticals (AUPH), had 32,424 shares withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. The shares were valued at $14.40 per share, totaling approximately $466,906. This was a tax-withholding disposition (Form 4 code F), not an open-market sale.

Key Details

• Transaction date: 2026-02-20; Filing date: 2026-02-23 (filing appears timely).
• Price per share: $14.40; Shares withheld/disposed: 32,424; Total value ≈ $466,906.
• Shares owned after transaction: not reported in the provided filing excerpt.
• Transaction code/footnote: F (tax withholding). Footnote F1: shares were withheld to satisfy tax withholding on RSU vesting.
• Nature of transaction: routine tax withholding on RSU vesting (disposition to the company/agent to cover taxes), not a discretionary market sale.

Context
Tax-withholding transactions on RSU vesting are common and generally considered administrative — they reduce an insider's reported shares outstanding but do not necessarily signal buying or selling intent. This filing documents that withholding; it does not indicate an open-market sale or new purchase.